Open access
Metronomic decitabine with venetoclax offers a patient-centered frontline therapeutic approach for TP53-mutated complex-karyotype myeloid neoplasms.
L. Walsh
Royce P. Lee
Joanathan Pan
Arun B. Dutta
Venkata Preetam Sandeep Kaduluri
Howard L. Li
Zachary B. Abrams
Philip R. O. Payne
Philip H. Imus
A. Ambinder
W. Dalton
Amy E. Dezern
Ivana Gojo
Tania Jain
Theodoros Karatanos
G. Prince
B. Smith
Jonathan A. Webster
Lukasz P. Gondek
Mark J. Levis
G. Ghiaur
Medicine
Abstract
Not available.